Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it
AssigneeAlfa Wassermann S.p.A.
InventorsEgidio Marchi, Gianfranco Tamagnone
Life of this patent
Estimating the term…
Abstract
The use of sulodexide, a glycosaminoglycan of natural origin extracted from mammalian intestinal mucosa, and of medicines containing it in the treatment of patients suffering from nephropathy of diabetic origin constitutes the object of the present invention. The effectiveness of sulodexide has been shown by the significative decrease of the albuminuria in microalbuminuric and macroalbuminuric diabetic patients treated with pharmaceutical compositions administered by oral or intramuscular route containing therapeutically effective amounts of drug.
Claims4
A method of treatment of diabetic nephropathy which consists of administering to a living subject affected by diabetic nephropathy, said living subject exhibiting microalbuminuria or macroalbuminuria, a therapeutically effective amount of sulodexide.
Dependencies are inferred from the claim text.